News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Macro sensitivity
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Dockside LLC has invested $5.70 million in Cameco Corporation (NYSE:CCJ), acquiring 55,948 shares, making it their 11th largest holding. Despite this new investment and strong institutional ownership, Cameco recently missed Q2 earnings expectations, reporting an adjusted EPS of $0.13 against a $0.26 consensus. Analyst …
AJB Investment Fund II, a 10% owner and director of Jewett Cameron Trading Co Ltd (JCTC), increased its stake by purchasing 16,978 shares worth $49,299 between August 12 and August 14, 2026. This insider buying occurs as JCTC shares have seen a 52% surge …
Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, has disclosed a beneficial ownership of 4,551,055 shares of Camping World Holdings, Inc.'s Class A common stock, representing 7.16% of the outstanding shares. This information comes from an amended passive investment disclosure …
Cameco Corp. (CCO) stock fell 0.40% on Friday to C$135.56, underperforming the broader Canadian market which saw the S&P/TSX Composite Index fall by 0.08%. The stock closed 25.8% below its 52-week high of C$182.72 reached on January 29th.
Camtek's stock price fell by 4.7% following insider selling activity, with CFO Moshe Eisenberg and Director Lior Aviram selling shares totaling approximately $1.26 million. Despite these sales, the company reported better-than-expected quarterly earnings and revenue, and analysts maintain a "Moderate Buy" consensus with an …
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …
Camtek Ltd. has filed a Form 144 notice indicating a proposed sale of 6,250 Ordinary Shares through Oppenheimer & Co. Inc., with an aggregate market value of $1,088,750.00. The filing notes 45,828,133 Ordinary Shares outstanding and details previous RSU vestings in 2023 and 2024 …
Hood River Capital Management LLC has filed an amended Schedule 13G/A, indicating that it no longer holds a reportable position in Camping World Holdings, Inc. (CWH) common stock. The filing shows Hood River now beneficially owns 0 shares, representing 0% of the outstanding common …
Camtek's Executive Chairman of the Board, Lior Aviram, recently sold shares worth US$1.1 million at an average price of US$168, reducing his holding by 35%. While this is the largest insider sale in the past year for Camtek, the insider ownership still stands at …
A shareholder of Camtek Ltd. (CAMT) has filed to sell 6,387 Ordinary Shares, with an aggregate market value of $1,112,615.40, through Oppenheimer & Co. Inc. on or after August 13, 2026. The filing also details prior issuances of Ordinary Shares from the vesting of …
Lior Aviram, an insider at Camtek Ltd. (CAMT), has filed a Form 144 to sell 3,347 ordinary shares with an aggregate market value of $583,047.40. These shares were acquired on June 1, 2026, from the vesting of Restricted Stock Units (RSUs). The filing also …
Balyasny Asset Management and its related entities have disclosed a beneficial ownership of approximately 4.99% in Camp4 Therapeutics Corp. (CAMP). This stake, totaling 2,591,097 shares, includes common stock and shares issuable upon warrant exercise, which are subject to a 4.99% Beneficial Ownership Limitation to …
Atria Investments Inc. has acquired a new stake in The Campbell's Company (NASDAQ:CPB), purchasing 50,994 shares valued at approximately $1,136,000 during the second quarter. This move is part of broader institutional investor activity, with several other firms also adjusting their positions in Campbell's. The …
CAMP4 Therapeutics Corporation (CAMP) reported a Q2 loss of $0.22 per share, outperforming the Zacks Consensus Estimate of a $0.24 loss. The company's revenues for the quarter ended June 2026 reached $1.78 million, surpassing estimates by 31.78%. Despite beating earnings and revenue expectations, CAMP …
J.P. Morgan has reiterated its Hold rating on Camden Property Trust (CPT.US) while increasing the target price to $114. This indicates a maintained neutral outlook on the company's stock, despite a raised valuation expectation.
Camden Property Trust (CPT) stock increased by 1.93% to $110.47, outperforming the broader market during a favorable trading session. The S&P 500 Index rose 0.65% and the Dow Jones Industrial Average rose 0.13%. This marks the second consecutive day of gains for Camden Property …
CAMP4 Therapeutics reported a Q2 net loss of $33.5 million, significantly wider than the previous year, primarily due to a $20.9 million non-cash derivative loss, causing EPS of $(0.58) to miss estimates. Despite missing revenue consensus, the company's revenue rose 18.8% year-over-year. Post-quarter, CAMP4 …
This article examines three U.S. consumer discretionary and retail stocks—MarineMax (HZO), Winnebago Industries (WGO), and Camping World Holdings (CWH)—that could benefit from cooling inflation and a less aggressive Federal Reserve. These companies, operating in sectors dependent on big-ticket spending, are navigating shifting economic conditions, …
CAMP4 Therapeutics reported a wider net loss of $33.5 million in Q2 2026, primarily due to a non-cash loss from a derivative liability. Despite this, the company's research and collaboration revenue increased, and it successfully extended its cash runway through the end of 2028 …
CAMP4 Therapeutics reported a widened net loss of $51.86 million for the six months ended June 30, 2026, primarily due to a $27.12 million non-cash charge from the remeasurement of a derivative tranche liability. Despite the loss, the company extended its cash runway through …
CAMP4 Therapeutics announced its Q2 2026 financial results and corporate highlights, including securing regulatory clearance in Australia and Argentina for its Phase 1/2 clinical trial of CMP-002 for SYNGAP-1 related disorder, with trial initiation expected in Q4 2026. The company also raised an additional …
Cameco Corp. (CCO) stock fell by 1.44% on Thursday, closing at C$136.10, while the broader Canadian market saw gains. The company's shares are currently trading 25.5% below their 52-week high of C$182.72, which was reached on January 29th. This performance marked an underperformance compared …
Quick Read SanDisk's 80% gross margin targets and signed contracts covering two-thirds of FY2028 bits drove LRCX up 4%, the most direct equipment beneficiary. AMAT reports Q3 earnings after today's close, while KLAC has already surged 72% year-to-date as equipment stocks get re-rated on …
Sharemaestro market context Price above Trend Line 52 weeks +85.2% · Next-week setup positive 55.2%Orit Geva-dvash, VP of HR at Camtek Ltd (CAMT), sold 415 shares for approximately $72,235, bringing her total direct holdings to 5,713 shares. This sale is the only insider transaction in the past year, with no corresponding buys, suggesting insiders may view the stock …
JP Morgan has maintained a "Neutral" rating on Camden Property Trust (CPT), raising its price target to $114. According to GuruFocus, CPT is currently undervalued by 1.9% with a GF Value™ of $112.63 and has a GF Score™ of 77/100. While institutional investors show …
JPMorgan Chase & Co. has raised its price target for Camden Property Trust (CPT) from $113 to $114, maintaining a "neutral" rating and suggesting a 3.3% upside. Other analysts have also adjusted their ratings and price targets for CPT, with the stock currently holding …
An insider at Camtek (CAMT) recently sold shares valued at $1,127,473, as disclosed in a recent SEC filing. The article highlights other recent news concerning Camtek, including another insider share sale worth $713,024 and analyst rating adjustments from Morgan Stanley and B. Riley. It …
Camtek CFO Moshe Eisenberg sold 645 shares of the company's stock on August 12th for $111,372, reducing his ownership by 3.82% to 16,239 shares. This follows a larger sale of 3,759 shares on August 11th for approximately $601,666. Despite the insider selling, Camtek reported …
Camtek's CFO, Moshe Eisenberg, sold a significant portion of his company stock in two separate transactions in August 2026, totaling over $712,000. These sales reduced his direct ownership by 18.21%. Despite the insider selling, Camtek's stock saw a slight increase, and the company reported …
Search by ticker symbol or company name and select a result to open its chart.